Equity Overview
Price & Market Data
Price: $1.99
Daily Change: $0.00 / 0.00%
Range: $1.99 - $2.00
Market Cap: $7,591,551
Volume: 405
Performance Metrics
1 Week: 0.51%
1 Month: -19.43%
3 Months: -57.93%
6 Months: -70.08%
1 Year: -92.99%
YTD: -53.94%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country: Germany
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.